FDA updates patient and provider fact sheets for mRNA COVID-19 vaccines; revises bronchoscope reprocessing safety recommendations
![FDA-guidance](/sites/default/files/styles/900x400/public/2018-07/FDA-guidance.jpg?itok=I8jaZmAO)
The Food and Drug Administration June 25 formally updated its patient and provider fact sheets for the Moderna and Pfizer COVID-19 vaccines to include warnings about the increased risk of heart inflammation in patients.
FDA also revised its safety recommendations for bronchoscope reprocessing. The agency now recommends health care facilities and staff consider sterilization over high-level disinfection when reprocessing. Other requests include not using damaged devices or those that have failed a leak test and performing preventive maintenance and proper inspection of bronchoscopes
Related News Articles
Headline
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
The Food and Drug Administration’s independent Nonprescription Drugs Advisory Committee Sept. 12 by unanimous vote declared oral phenylephrine…
Headline
The Senate Health, Education, Labor and Pensions Committee today 17-3 to pass as amended the Pandemic and All-Hazards Preparedness and Response Act (S. 2333),…
Headline
The Food and Drug Administration’s vaccine advisory committee June 15 voted unanimously to recommend updating the current COVID-19 vaccine composition for…